LAUSR

Previous studies have demonstrated that patients in the United States (US) who lack private or government-based health insurance who suffer from a variety of malignancies have shortened survival compared to their insured counterparts. Additionally, low-income patients in the US with breast and colon cancers have worse survival outcomes than low-income patients who reside in countries with universal healthcare. Despite the implementation of the Affordable Care Act in 2010, 28 million Americans remain uninsured and struggle to access medical care. Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) are generally indolent with a favorable prognosis, and patients frequently undergo multiple operative and non-operative interventions that have the potential to dramatically alter their clinical course. Until now, how insurance status impacts survival following GEP-NET resection remained unexplored.